Try it
Ophthalmology · Pharmacology: anti-VEGF
Sample itemWhich agent is an intravitreal anti-VEGF drug commonly used off label for retinal disease?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Bevacizumab
Bevacizumab is a full-length antibody to VEGF-A that is widely used off label. Ranibizumab and aflibercept are approved agents, and endophthalmitis is a rare procedural risk.
Option by option
A. Timolol
Timolol is a beta-blocker.
B. Bevacizumab (correct)
Correct. Bevacizumab blocks VEGF-A.
C. Natamycin
Natamycin is an antifungal.
D. Atropine
Atropine is a cycloplegic.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Ophthalmology questions
- GlaucomaWhich topical glaucoma medicine lowers intraocular pressure mainly by increasing uveoscl…
- Ocular oncologyA 2-year-old child has a white pupillary reflex (leukocoria). The gene commonly involved…
- UveaA patient has a painful red eye with photophobia, ciliary congestion, a small irregular…
- GlaucomaWhich drug is given systemically to reduce intraocular pressure in acute angle-closure g…